Total synthesis of hibarimicinone, a v-Src tyrosine kinase inhibitor possessing the pseudo-dimer structure of tetracycline

Kuniaki Tatsuta, Seijiro Hosokawa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The total synthesis of hibarimicinone, a potent v-Src tyrosine kinase inhibitor possessing thirteen stereogenic centers and an axial chirality, has been achieved. The key step to constructing the eight-ring skeleton was the double Michael-Dieckmann-type cyclization (Hauser annulation) using a thiolactone pseudo-dimer. These synthetic studies indicated the efficiency of the thiolactone-employed route to synthesize the multiply functionalized polycyclic compounds. The ABCD-ring moiety including the bridging ether was constructed by a strategy including oxidation of the C-ring hydroquinone and the subsequent transfer of the oxidation stage to the neighboring ring. The atropisomer of hibarimicinone was also synthesized to confirm the structure of the natural product. The total synthesis of hibarimicinone, a potent v-Src tyrosine kinase inhibitor, has been achieved. The key step to constructing the eight-ring skeleton was the double Michael-Dieckmann-type cyclization (Hauser annulation) using a thiolactone pseudo-dimer. The ABCD-ring moiety including the bridging ether was constructed by a strategy including oxidation of the C-ring hydroquinone and the subsequent transfer of the oxidation stage to the neighboring ring. The atropisomer of hibarimicinone was also synthesized to confirm the structure of the natural product.

Original languageEnglish
Pages (from-to)28-40
Number of pages13
JournalChemical Record
Volume14
Issue number1
DOIs
Publication statusPublished - 2014 Feb

Keywords

  • annulation
  • hibarimicinone
  • stereoselective synthesis
  • tetracycline
  • total synthesis

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry
  • Chemical Engineering(all)
  • Materials Chemistry

Fingerprint Dive into the research topics of 'Total synthesis of hibarimicinone, a v-Src tyrosine kinase inhibitor possessing the pseudo-dimer structure of tetracycline'. Together they form a unique fingerprint.

  • Cite this